Dual Growth Factor (rhTPO + G-CSF) and Chemotherapy Combination Regimen for Elderly Patients with Acute Myeloid Leukemia: A Phase II Single-Arm Multicenter Study

Acute myeloid leukemia (AML) is a disease affecting older adults, although optimal strategies for treating such patients remain unclear. This prospective phase II, open-label, multicenter study was designed to assess the efficacy and safety of two hematologic growth factors, recombinant human thromb...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Xiaoyu, Shi, Hua, Shen, Jing, Li, Yang, Yan, Wei, Sun, Ying, Liao, Aijun, Tan, Yehui, Yang, Wei, Wang, Huihan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Clinical Trial Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8485918/
https://www.ncbi.nlm.nih.gov/pubmed/34611424
http://dx.doi.org/10.2147/IJGM.S323699

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8485918/
https://www.ncbi.nlm.nih.gov/pubmed/34611424
http://dx.doi.org/10.2147/IJGM.S323699

Ejemplares similares